{"id":2772,"date":"2026-04-01T14:51:14","date_gmt":"2026-04-01T14:51:14","guid":{"rendered":"https:\/\/www.homeworld.bio\/?p=2772"},"modified":"2026-04-01T15:02:48","modified_gmt":"2026-04-01T15:02:48","slug":"introducing-engineered-resilience-a-homeworld-spinout-initiative-focused-on-pollution-driven-disease","status":"publish","type":"post","link":"https:\/\/www.homeworld.bio\/blog\/introducing-engineered-resilience-a-homeworld-spinout-initiative-focused-on-pollution-driven-disease\/","title":{"rendered":"Introducing Engineered Resilience \u2014 A Homeworld Spinout Initiative Focused on Pollution-driven Disease"},"content":{"rendered":"
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n
\n
Visit Engineered Resilience<\/strong><\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

Targeting Pollutants as Drivers of Chronic Disease<\/strong><\/h2>\n\n\n\n

Many major chronic diseases in the US are labeled \u201cidiopathic,\u201d which is clinical shorthand for unknown causes of the disease. There has been limited attention on environmental factors that contribute to these diseases beyond lifestyle choices. Decades of research have indicated that anthropogenic chemicals such as air pollutants, pesticides, and heavy metals act as active agents of disease. Approximately 15% of the chronic disease burden in the U.S. is attributable to known pollutant exposures.<\/p>\n\n\n\n


At the same time, there is a clear gap in funding, talent, and applied research focused on biotech applications that respond to the cumulative effects of exposures to pollutants.<\/p>\n\n\n\n


The biology of pollutant exposure offers a window into the earliest phases of chronic illnesses. These exposures act as molecular probes that help us understand the damage to DNA, proteins, and cellular systems which contribute to disease onset. Yet this relationship remains underutilized by both biotech and major research institutions.<\/p>\n\n\n\n

\"\"<\/a>
Figure from Engineered Resilience website: documented links between environmental exposures and chronic disease.<\/em><\/figcaption><\/figure>\n\n\n\n


At Homeworld, Sarah Daniels led the Pollution Program to test how existing biotech tools could be used to measure and act on the biological effects of pollutant exposures. This builds on the longstanding vision from Daniel Goodwin, who helped shape the thesis and pushed for swift experimental validation. A key question arose during our roadmapping: Can biotechnology be used to detect and act on pollutant-driven damage before disease onset? <\/p>\n\n\n\n

This grew into a compelling human health thesis that requires sustained focus beyond Homeworld\u2019s scope, which led to the creation of Engineered Resilience<\/a> as Homeworld\u2019s first spinout.<\/p>\n\n\n\n

\n

The Thesis<\/strong><\/h2>\n<\/div>\n\n\n\n

Many chronic diseases are managed after symptoms appear. Even though earlier biological signals are presented, they are not routinely measured or acted on. Engineered Resilience focuses on identifying these signals in the context of exposures to pollutants and translating them into actionable biology, thereby increasing protection against these threats. If successful, this work could shift a meaningful share of chronic disease from downstream treatment to earlier intervention, improving millions of lives and avoiding trillions of dollars in healthcare costs over time. By focusing on human health as the fulcrum, pollution that is often treated as an externality becomes measurable and has solutions that carry a price tag. This can then be the lever to hold polluters accountable.<\/p>\n\n\n\n

In the near term, the roadmap focuses on using advanced biotech platforms to detect early biological signals from pollutant exposures and transfer them to biopharma-relevant applications.  Sarah will lead this field-building effort by advancing R&D through partnerships and new applications that explore molecular pathways which have been undervalued in biotech. The aim is to generate outputs, including biomarkers, molecular targets, and early-stage models, that improve understanding of chronic disease etiology and enable earlier intervention. Ultimately, the goal is to reduce the burden of chronic disease driven by pollutant exposures. Achieving this will require connecting practitioners across a fragmented solution space to building a cohesive pipeline that integrates complementary approaches, moving promising findings into real-world use.<\/p>\n\n\n\n

What We\u2019ve Built So Far<\/strong><\/h2>\n\n\n\n

Over the past year, Sarah built the Pollution Program into a set of active projects, collaborations and field-building opportunities:<\/p>\n\n\n\n